QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)

Avidity Biosciences (RNA) Short Interest Ratio & Short Volume

$15.26
-0.05 (-0.33%)
(As of 02/28/2024 ET)

Avidity Biosciences Short Interest Data

Current Short Volume
7,730,000 shares
Previous Short Volume
7,640,000 shares
Change Vs. Previous Month
+1.18%
Dollar Volume Sold Short
$104.59 million
Short Interest Ratio / Days to Cover
5.4
Last Record Date
February 15, 2024
Outstanding Shares
74,100,000 shares
Percentage of Shares Shorted
10.43%
Today's Trading Volume
841,361 shares
Average Trading Volume
979,674 shares
Today's Volume Vs. Average
86%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Avidity Biosciences ?

Sign up to receive the latest short interest report for Avidity Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RNA Short Interest Over Time

RNA Days to Cover Over Time

RNA Percentage of Float Shorted Over Time


Avidity Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/20247,730,000 shares $104.59 million +1.2%N/A5.4 $13.53
1/31/20247,640,000 shares $93.44 million +4.1%N/A5.4 $12.23
1/15/20247,340,000 shares $83.31 million -25.3%N/A5.5 $11.35
12/31/20239,830,000 shares $88.96 million -8.0%N/A7.4 $9.05
12/15/202310,680,000 shares $92.38 million -3.2%N/A8.5 $8.65
11/30/202311,030,000 shares $86.14 million +1.5%N/A9 $7.81
11/15/202310,870,000 shares $67.72 million -6.3%N/A13.7 $6.23
10/31/202311,600,000 shares $59.74 million +0.3%N/A14.7 $5.15
10/15/202311,570,000 shares $71.50 million -25.3%N/A14.5 $6.18
9/30/202315,490,000 shares $98.83 million -7.4%N/A20.3 $6.38
9/15/202316,720,000 shares $117.21 million +2.1%N/A21.3 $7.01
8/31/202316,380,000 shares $123.83 million +2.0%N/A18.2 $7.56
8/15/202316,060,000 shares $139.40 million +2.8%N/A17.9 $8.68
7/31/202315,620,000 shares $148.55 million -2.7%N/A15.7 $9.51
7/15/202316,050,000 shares $173.82 million +2.2%N/A13.4 $10.83
6/30/202315,710,000 shares $174.22 million +11.4%N/A12 $11.09
6/15/202314,100,000 shares $175.97 million +5.2%N/A9.7 $12.48
5/31/202313,400,000 shares $142.31 million +4.4%N/A10.1 $10.62
5/15/202312,840,000 shares $144.45 million +29.3%N/A9.5 $11.25
4/30/20239,930,000 shares $123.13 million -12.4%N/A7.6 $12.40
4/15/202311,330,000 shares $169.72 million +3.9%N/A10.6 $14.98
3/31/202310,910,000 shares $167.47 million +25.6%N/A10.5 $15.35
3/15/20238,690,000 shares $184.05 million +4.6%N/A9.1 $21.18
2/28/20238,310,000 shares $196.95 million +5.5%N/A4.2 $23.70
2/15/20237,880,000 shares $194.64 million +5.1%N/A4.1 $24.70
1/31/20237,500,000 shares $177.75 million -4.7%N/A3.9 $23.70
1/15/20237,870,000 shares $178.26 million -5.0%N/A4.1 $22.65
12/30/20228,280,000 shares $183.73 million +27.2%N/A4.5 $22.19
12/15/20226,510,000 shares $118.16 million -7.3%N/A3.6 $18.15
11/30/20227,020,000 shares $81.71 million -0.1%N/A11.6 $11.64
11/15/20227,030,000 shares $100.53 million +26.7%N/A13.2 $14.30
10/31/20225,550,000 shares $79.25 million +12.6%N/A11.8 $14.28
10/15/20224,930,000 shares $80.90 million +7.4%N/A11.1 $16.41
9/30/20224,590,000 shares $74.95 million -13.4%N/A11.8 $16.33
9/15/20225,300,000 shares $112.36 million +0.8%N/A16.3 $21.20
8/31/20225,260,000 shares $103.20 million -5.6%N/A15.1 $19.62
8/15/20225,570,000 shares $123.71 million -4.5%N/A15.5 $22.21
7/31/20225,830,000 shares $94.97 million -1.2%N/A15.8 $16.29
7/15/20225,900,000 shares $103.43 million +4.1%N/A16.6 $17.53
6/30/20225,670,000 shares $82.39 million +15.0%N/A16.4 $14.53













RNA Short Interest - Frequently Asked Questions

What is Avidity Biosciences' current short interest?

Short interest is the volume of Avidity Biosciences shares that have been sold short but have not yet been covered or closed out. As of February 15th, investors have sold 7,730,000 shares of RNA short. Learn More on Avidity Biosciences' current short interest.

What is a good short interest ratio for Avidity Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RNA shares currently have a short interest ratio of 5.0. Learn More on Avidity Biosciences's short interest ratio.

Which institutional investors are shorting Avidity Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avidity Biosciences: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Avidity Biosciences' short interest increasing or decreasing?

Avidity Biosciences saw a increase in short interest in February. As of February 15th, there was short interest totaling 7,730,000 shares, an increase of 1.2% from the previous total of 7,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Avidity Biosciences' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Avidity Biosciences: Centessa Pharmaceuticals plc (2.85%), Geron Co. (8.02%), Innoviva, Inc. (19.51%), Amylyx Pharmaceuticals, Inc. (9.58%), MacroGenics, Inc. (10.97%), Immunome, Inc. (7.03%), Zentalis Pharmaceuticals, Inc. (20.19%), MannKind Co. (12.85%), Arcturus Therapeutics Holdings Inc. (18.57%), Edgewise Therapeutics, Inc. (8.55%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Avidity Biosciences stock?

Short selling RNA is an investing strategy that aims to generate trading profit from Avidity Biosciences as its price is falling. RNA shares are trading down $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Avidity Biosciences?

A short squeeze for Avidity Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RNA, which in turn drives the price of the stock up even further.

How often is Avidity Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNA, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:RNA) was last updated on 2/28/2024 by MarketBeat.com Staff